Psychedelic Bulletin: MindMed to List on Nasdaq; Atai IPO Unveiled; Champignon Brands Resumes Trading Post published:April 23, 2021 Post category:Psychedelic Bulletin
Champignon Brands Announces Revocation of Cease Trade Orders Post published:April 22, 2021 Post category:Press Release
Silo Pharma (SILO) Announces Plans to Uplist to the NASDAQ Post published:April 22, 2021 Post category:Press Release
Revive Therapeutics Announces Successful Research Results for Oral Thin Film Psilocybin and Filing of U.S. Provisional Patent Application Post published:April 22, 2021 Post category:Press Release
Aion Therapeutic’s Proprietary Mushroom Preparations Shown Effective in Killing Breast Cancer Cells Post published:April 21, 2021 Post category:Press Release
Cybin Demonstrates Proof of Concept of Its Deuterated Tryptamines for the Treatment of Depression and Addiction Post published:April 21, 2021 Post category:Press Release
MINDCURE Partners its iSTRYM Technology with LUCID to Discover and Create Proprietary Music Experiences for Use During Psychedelic-Assisted Therapy Sessions Post published:April 21, 2021 Post category:Press Release
Red Light Holland Increases Points of Sale for iMicrodose Packs in the Netherlands by More Than 140% Post published:April 21, 2021 Post category:Press Release
Silo Wellness Announces Five New Psychedelic Wellness Retreats in Jamaica Post published:April 21, 2021 Post category:Press Release